Identifying Medication Targets for Psychostimulant Addiction: Unraveling the Dopamine D3 Receptor Hypothesis

作者: Thomas M Keck , William S John , Paul W Czoty , Michael A Nader , Amy Hauck Newman

DOI: 10.1021/JM501512B

关键词: ChemistrySubstance useAddictionPharmacologyDrug discoveryHuman studiesDrugNeuroscienceSubstance abuseDopamine receptor D3Partial agonist

摘要: The dopamine D3 receptor (D3R) is a target for developing medications to treat substance use disorders. D3R-selective compounds with high affinity and varying efficacies have been discovered, providing critical research tools cell-based studies that translated in vivo models of drug abuse. D3R antagonists partial agonists shown especially promising results rodent relapse-like behavior, including stress-, drug-, cue-induced reinstatement seeking. However, date, translation human has limited. Herein, we present an overview illustrate some the pitfalls challenges novel toward clinical utility, treatment cocaine Future development abuse remains critically important but will also require further evaluation translational animal determine best time addicti...

参考文章(177)
Bernard Le Foll, Ginetta Collo, Eugenii A. Rabiner, Isabelle Boileau, Emilio Merlo Pich, Pierre Sokoloff, Dopamine D3 receptor ligands for drug addiction treatment: update on recent findings. Progress in Brain Research. ,vol. 211, pp. 255- 275 ,(2014) , 10.1016/B978-0-444-63425-2.00011-8
Rui Song, Ri-Fang Yang, Ning Wu, Rui-Bin Su, Jin Li, Xiao-Qing Peng, Xia Li, József Gaál, Zheng-Xiong Xi, Eliot L. Gardner, YQA14: a novel dopamine D3 receptor antagonist that inhibits cocaine self-administration in rats and mice, but not in D3 receptor-knockout mice. Addiction Biology. ,vol. 17, pp. 259- 273 ,(2012) , 10.1111/J.1369-1600.2011.00317.X
Christian A. Heidbreder, Amy H. Newman, Current perspectives on selective dopamine D(3) receptor antagonists as pharmacotherapeutics for addictions and related disorders. Annals of the New York Academy of Sciences. ,vol. 1187, pp. 4- 34 ,(2010) , 10.1111/J.1749-6632.2009.05149.X
Thomas M Keck, Mu‐Fa Zou, Guo‐Hua Bi, Hai‐Ying Zhang, Xiao‐Fei Wang, Hong‐Ju Yang, Ratika Srivastava, Eliot L Gardner, Zheng‐Xiong Xi, Amy Hauck Newman, None, A novel mGluR5 antagonist, MFZ 10‐7, inhibits cocaine‐taking and cocaine‐seeking behavior in rats Addiction Biology. ,vol. 19, pp. 195- 209 ,(2014) , 10.1111/ADB.12086
Jeremy Shonberg, Laura Lopez, Peter J. Scammells, Arthur Christopoulos, Ben Capuano, J. Robert Lane, Biased agonism at G protein-coupled receptors: the promise and the challenges--a medicinal chemistry perspective. Medicinal Research Reviews. ,vol. 34, pp. 1286- 1330 ,(2014) , 10.1002/MED.21318
Laura Orio, Sunmee Wee, Amy H Newman, Luigi Pulvirenti, George F Koob, None, The dopamine D3 receptor partial agonist CJB090 and antagonist PG01037 decrease progressive ratio responding for methamphetamine in rats with extended-access. Addiction Biology. ,vol. 15, pp. 312- 323 ,(2010) , 10.1111/J.1369-1600.2010.00211.X
Kyle C. Schmitt, Maarten E. A. Reith, Regulation of the dopamine transporter Annals of the New York Academy of Sciences. ,vol. 1187, pp. 316- 340 ,(2010) , 10.1111/J.1749-6632.2009.05148.X
Eliot L. Gardner, Stanislav R. Vorel, Charles R. Ashby, Mousumi Paul, Xinhe Liu, Robert Hayes, Jim J. Hagan, Derek N. Middlemiss, Geoffrey Stemp, Dopamine D3 Receptor Antagonism Inhibits Cocaine-Seeking and Cocaine-Enhanced Brain Reward in Rats The Journal of Neuroscience. ,vol. 22, pp. 9595- 9603 ,(2002) , 10.1523/JNEUROSCI.22-21-09595.2002
Julie K. Staley, Deborah C. Mash, Adaptive Increase in D3 Dopamine Receptors in the Brain Reward Circuits of Human Cocaine Fatalities The Journal of Neuroscience. ,vol. 16, pp. 6100- 6106 ,(1996) , 10.1523/JNEUROSCI.16-19-06100.1996
David M Segal, Carlos T Moraes, Deborah C Mash, Up-regulation of D3 dopamine receptor mRNA in the nucleus accumbens of human cocaine fatalities Molecular Brain Research. ,vol. 45, pp. 335- 339 ,(1997) , 10.1016/S0169-328X(97)00025-9